Seguir
H Raza Ali
H Raza Ali
Group Leader, CRUK Cambridge Institute, University of Cambridge
Dirección de correo verificada de cruk.cam.ac.uk - Página principal
Título
Citado por
Citado por
Año
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
20852012
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...
Annals of oncology 25 (8), 1536-1543, 2014
8462014
The single-cell pathology landscape of breast cancer
HW Jackson, JR Fischer, VRT Zanotelli, HR Ali, R Mechera, SD Soysal, ...
Nature 578 (7796), 615-620, 2020
7032020
Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study
HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas
PLoS medicine 13 (12), e1002194, 2016
5712016
Prognostic and predictive value of PDL1 expression in breast cancer
R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ...
Oncotarget 6 (7), 5449, 2015
5492015
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 8760, 2015
5262015
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
4762012
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
4112013
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes
HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ...
Annals of Oncology 26 (7), 1488-1493, 2015
3292015
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ...
Nature 567 (7748), 399-404, 2019
3232019
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
HR Ali, HW Jackson, VRT Zanotelli, E Danenberg, JR Fischer, H Bardwell, ...
Nature Cancer 1 (2), 163-175, 2020
2512020
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ...
Genome biology 15, 1-14, 2014
2482014
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
G Friedman, O Levi-Galibov, E David, C Bornstein, A Giladi, M Dadiani, ...
Nature Cancer 1 (7), 692-708, 2020
2222020
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
2022016
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
WT Khaled, S Choon Lee, J Stingl, X Chen, H Raza Ali, OM Rueda, ...
Nature communications 6 (1), 5987, 2015
1702015
Breast tumor microenvironment structures are associated with genomic features and clinical outcome
E Danenberg, H Bardwell, VRT Zanotelli, E Provenzano, SF Chin, ...
Nature genetics 54 (5), 660-669, 2022
1482022
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ...
EMBO molecular medicine 3 (3), 167-180, 2011
1422011
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas
Breast Cancer Research 13, 1-15, 2011
1382011
The genomic and immune landscapes of lethal metastatic breast cancer
L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...
Cell reports 27 (9), 2690-2708. e10, 2019
1142019
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
M Álvarez-Fernández, M Sanz-Flores, B Sanz-Castillo, M Salazar-Roa, ...
Cell Death & Differentiation, 1-13, 2017
952017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20